指南与共识膀胱癌与上尿路尿路上皮癌

T1期膀胱癌二次电切的相关因素:人群水平识别未接受指南一致治疗的患者

Factors Associated with Re-Resection in T1 Bladder Cancer: Identifying Patients Who Do Not Receive Guideline-Concordant Care at the Population Level.
指南 / 共识 · J Urol · 2021-09-22

该研究基于加拿大安大略省2001至2015年全省膀胱癌病理报告与健康行政数据,构建T1期膀胱癌患者队列,分析二次电切的相关因素。共纳入7373例患者,仅1678例(23%)在初次电切后2至8周内接受二次电切。更具侵袭性肿瘤特征、肌层固有层采样不足以及年轻、健康、社会经济优势患者更可能接受二次电切;资深、低手术量和男性外科医生更少实施二次电切。

要点

  • 仅23%的T1期膀胱癌患者在初次电切后2至8周内接受二次电切。
  • 肌层固有层采样不足及更具侵袭性肿瘤特征者更可能接受二次电切。
  • 资深、低手术量和男性外科医生更少实施二次电切。

核心结论

  • 仅少数T1期膀胱癌患者在初次电切后2至8周内接受二次电切。
  • 建议实施知识转化与交流干预以改善可能服务不足患者的就医可及性。

研究设计与样本

  • 纳入7373例符合标准的T1期膀胱癌患者。
  • 二次电切定义为初次电切后2至8周内经尿道电切的收费记录。
  • 采用多变量逻辑回归分析,考虑数据聚类性质,识别患者层面和外科医生层面因素。
  • P值<0.05(双侧)认为有统计学意义。

主要发现

  • 共7373例患者,1678例(23%)接受二次电切。
  • 更具侵袭性肿瘤特征、肌层固有层采样不足、年轻、健康及社会经济优势患者更可能接受二次电切(均p<0.05)。
  • 更资深、低手术量及男性外科医生更少为患者实施二次电切(均p<0.05)。

关键数值与推荐

  • 二次电切时间窗为初次电切后2至8周。
  • 统计学显著性阈值P<0.05(双侧)。

临床怎么用

  • 应关注肌层固有层采样不足的T1期膀胱癌患者,确保其接受二次电切。
  • 针对资深、低手术量及男性外科医生,可实施知识转化与交流干预以提高指南一致性。
  • 需关注年轻、健康及社会经济优势患者以外可能服务不足人群的二次电切可及性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Prior research has shown that concordance with the guideline-endorsed recommendation to re-resect patients diagnosed with primary T1 bladder cancer (BC) is suboptimal. Therefore, the aim of this population-based study was to identify factors associated with re-resection in T1 BC. MATERIALS AND METHODS: We linked province-wide BC pathology reports (January 2001 to December 2015) with health administrative data sources to derive an incident cohort of patients diagnosed with T1 BC in the province of Ontario, Canada. Re-resection was ascertained by a billing claim for transurethral resection within 2 to 8 weeks after the initial resection, accounting for system-related wait times. Multivariable logistic regression analysis accounting for the clustered nature of the data was used to identify various patient-level and surgeon-level factors associated with re-resection. P values <0.05 were considered statistically significant (2-sided). RESULTS: We identified 7,373 patients who fulfilled the inclusion criteria. Overall, 1,678 patients (23%) underwent re-resection. Patients with a more aggressive tumor profile and individuals without sufficiently sampled muscularis propria as well as younger, healthier and socioeconomically advantaged patients were more likely to receive re-resection (all p <0.05). In addition, more senior, lower volume and male surgeons were less likely to perform re-resection for their patients (all p <0.05). CONCLUSIONS: Only a minority of all patients received re-resection within 2 to 8 weeks after initial resection. To improve the access to care for potentially underserved patients, we suggest specific knowledge translation/exchange interventions that also include equity aspects besides further promotion of evidence-based instead of eminence-based medicine.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Wettstein MS, Baxter NN, Sutradhar R, et al. Factors Associated with Re-Resection in T1 Bladder Cancer: Identifying Patients Who Do Not Receive Guideline-Concordant Care at the Population Level. J Urol. 2021. PMID: 34547923. doi:10.1097/JU.0000000000002229

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。